Evidence map›Paper›PMID 21610753›Full record

ArticleEuropean journal of human genetics : EJHG2011

Assessing the pathological relevance of SPINK1 promoter variants.

Arnaud Boulling, Heiko Witt, Giriraj Ratan Chandak, Emmanuelle Masson, Sumit Paliwal, Seema Bhaskar, D Nageshwar Reddy, David N Cooper, Jian-Min Chen, Claude Férec

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Functional significance of SPINK1 promoter variants in chronic pancreatitis.American journal of physiology. Gastrointestinal and liver physiology · 2015
    Article
  7. Review
  8. Framework for interpretation of trypsin-antitrypsin imbalance and genetic heterogeneity in pancreatitis.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Arnaud BoullingInstitut National de Santé et de Recherche Médicale (INSERM), U613, Brest, France.
Heiko Witt
Giriraj Ratan Chandak
Emmanuelle Masson
Sumit Paliwal
Seema Bhaskar
D Nageshwar Reddy
David N Cooper
Jian-Min Chen
Claude Férec
Centre for Cellular and Molecular Biology · INInserm · FRAsian Institute of Gastroenterology · INCardiff University · GBCentre Hospitalier Régional Universitaire de Brest · FRElse Kröner-Fresenius-Stiftung · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SPINK1 gene, encoding the human pancreatic secretory trypsin inhibitor, is one of the major genes involved in predisposition to chronic pancreatitis (CP). In this study we have assessed the potential functional impact of 11 SPINK1 promoter variants by means of both luciferase reporter gene assay and electrophoretic mobility shift assay (EMSA), using human pancreatic COLO-357 cells as an expression system. The 11 promoter variants were found to be separable into three distinct categories on the basis of the reporter gene assay results viz loss-of-function, gain-of-function and functionally neutral. These findings, which were validated by EMSA, concurred with data from previous deletion studies and DNase I footprinting assays. Further, binding sites for two transcription factors, HNF1 and PTF1, were newly identified within the SPINK1 promoter by virtue of their being affected by specific variants. Combining the functional data with epidemiological data (derived by resequencing the SPINK1 promoter region in French, German and Indian CP patients and controls), then allowed us to make meaningful inferences as to each variant's likely contribution to CP. We conclude that only the three promoter variants associated with a loss-of-function (ie, -53C>T, -142T>C and -147A>G) are likely to be disease-predisposing alterations.

Indexed as

Genetic Predisposition to DiseaseCarrier ProteinsCase-Control StudiesCell LineCell Line, TumorElectrophoretic Mobility Shift AssayFranceGenes, ReporterGenetic TestingGenetic VariationGermanyHumansIndiaKidneyMutationPancreasCarrier ProteinsSPINK1 protein, humanTrypsin Inhibitor, Kazal Pancreatic

Identifiers

PMID21610753
PMCPMC3190254
OpenAlexW2154967850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.